Interaction between drug and placebo effects: A cross-over balanced placebo design trial

Trials

Volumn 11, Issue , 2010, Pages

  Hammami, Muhammad M ^a   Al Gaai, Eman A ^a   Alvi, Syed ^a   Hammami, Muhammad B ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; PLACEBO;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG CAPSULE; DRUG CLEARANCE; DRUG EFFECT; DRUG HALF LIFE; DRUG INTERACTION; DRUG MECHANISM; DRUG RESEARCH; ENERGY; FEMALE; FLUSHING; HEADACHE; HUMAN; HUMAN EXPERIMENT; INTERVENTION STUDY; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; NAUSEA; NORMAL HUMAN; OUTCOME ASSESSMENT; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; SOMNOLENCE; SYSTOLIC BLOOD PRESSURE; VISUAL ANALOG SCALE;

ADULT; CAFFEINE; CROSS-OVER STUDIES; HUMANS; PLACEBO EFFECT; RESEARCH DESIGN;

EID: 78349265786     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-11-110     Document Type: Article

References (33)

1. Tilburt JC, Emanuel EJ, Kaptchuk TJ, Curlin FA, Miller FG. Prescribing placebo treatments: Results of national survey of US internists and rheumatologists. BMJ 2008, 337:a1983. 10.1136/bmj.a1938, 18840633.
2. Hróbjartsson A, Gøtzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001, 344:1594-1602. 10.1056/NEJM200105243442106, 11372012.
3. Hróbjartsson A, Gøtzsche PC. Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment. J Intern Med 2004, 256:91-100. 10.1111/j.1365-2796.2004.01355.x, 15257721.
4. Moerman DE, Jonas WB. Deconstructing the placebo effect and finding the meaning response. Ann Intern Med 2002, 136:471-476.
5. Fillingim RB, Price DD. What is controlled for in placebo-controlled trials?. Mayo Clin Proc 2005, 80:1119-1121. 10.4065/80.9.1119, 16178490.
6. Spiegel D, Harrington A. What is the placebo worth? The doctor-patient relationship is a crucial part of its value. BMJ 2008, 336:967-968. 10.1136/bmj.39535.344201.BE, 18390494.
7. Oken BS. Placebo effects: clinical aspects and neurobiology. Brain 2008, 131:2812-2823. 10.1093/brain/awn116, 2725026, 18567924.
8. Miller FG, Wendler D, Swartzman LC. Deception in research on the placebo effect. PLoS Med 2005, 2:e262. 10.1371/journal.pmed.0020262, 1198039, 16173830.
9. Kienle GS, Kiene H. The powerful placebo effect: fact or fiction?. J Clin Epidemiol 1997, 50:1311-1318. 10.1016/S0895-4356(97)00203-5, 9449934.
10. Barfod TS. Placebos in medicine: Placebo use is well known, placebo effect is not. BMJ 2005, 330:45. 10.1136/bmj.330.7481.45, 539859, 15626818.
11. McPherson K. Do patients' preferences matter? Yes, but to what extent is unclear. BMJ 2008, 337:a2034. 10.1136/bmj.a2034, 18977793.
12. de Craen AJ, Kaptchuk TJ, Tijssen JG, Kleijnen J. Placebos and placebo effects in medicine: historical overview. J R Soc Med 1999, 92:511-515. 1297390, 10692902.
13. Lotshaw SC, Bradley JR, Brooks LR. Illustrating caffeine's pharmacological and expectancy effects utilizing a balanced placebo design. J Drug Educ 1996, 26:13-24.
14. Gundersen H, Specht K, Grüner R, Ersland L, Hugdahl K. Separating the effects of alcohol and expectancy on brain activation: an fMRI working memory study. Neuroimage 2008, 42:1587-1596. 10.1016/j.neuroimage.2008.05.037, 18588989.
15. Cole-Harding S, Michels VJ. Does expectancy affect alcohol absorption?. Addict Behav 2007, 32:194-198. 10.1016/j.addbeh.2006.03.042, 16713125.
16. Kelemen WL, Kaighobadi F. Expectancy and pharmacology influence the subjective effects of nicotine in a balanced-placebo design. Exp Clin Psychopharmacol 2007, 15:93-101. 10.1037/1064-1297.15.1.93, 2239264, 17295588.
17. Green MW, Taylor MA, Elliman NA, Rhodes O. Placebo expectancy effects in the relationship between glucose and cognition. Br J Nutr 2001, 86:173-179. 10.1079/BJN2001398, 11502230.
18. Pohl J, Frohnau G, Kerner W, Fehm-Wolfsdorf G. Symptom awareness is affected by the subjects' expectations during insulin-induced hypoglycemia. Diabetes Care 1997, 20:796-802. 10.2337/diacare.20.5.796, 9135945.
19. Price DD. Assessing placebo effects without placebo groups: an untapped possibility?. Pain 2001, 90:201-203. 10.1016/S0304-3959(01)00265-2, 11207391.
20. Sayette MA, Breslin FC, Wilson GT, Rosenblum GD. An evaluation of the balanced placebo design in alcohol administration research. Addict Behav 1994, 19:333-342. 10.1016/0306-4603(94)90034-5, 7942250.
21. Kirsch I, Moore TJ, Scoboria A, Nicholls SS. The emperor's new drugs: An analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration. Prevention & Treatment 2002, 5:23., http://alphachoices.com/repository/assets/pdf/EmperorsNewDrugs.pdf
22. Waring DR. The antidepressant debate and the balanced placebo trial design: an ethical analysis. Int J Law Psychiatry 2008, 31:453-462. 10.1016/j.ijlp.2008.09.001, 18954907.
23. Krogsbøll LT, Hróbjartsson A, Gøtzsche PC. Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention. BMC Med Res Methodol 2009, 9:1. 10.1186/1471-2288-9-1, 2628943, 19123933.
24. Mort JR, Kruse HR. Timing of blood pressure measurement related to caffeine consumption. Ann Pharmacother 2008, 42:105-110.
25. Juliano LM, Griffiths RR. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology 2004, 176:1-29. 10.1007/s00213-004-2000-x, 15448977.
26. Dickert N, Grady C. What's the price of a research subject? Approaches to payment for research participation. N Engl J Med 1999, 341:198-203. 10.1056/NEJM199907153410312, 10403861.
27. Kamimori GH, Karyekar CS, Otterstetter R, Cox DS, Balkin TJ, Belenky GL, Eddington ND. The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers. Int J Pharm 2002, 234:159-167. 10.1016/S0378-5173(01)00958-9, 11839447.
28. McRae C, Cherin E, Yamazaki TG, Diem G, Vo AH, Russell D, Ellgring JH, Fahn S, Greene P, Dillon S, Winfield H, Bjugstad KB, Freed CR. Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. Arch Gen Psychiatry 2004, 61:412-420. 10.1001/archpsyc.61.4.412, 15066900.
29. Preference Collaborative Review Group Patients' preferences within randomised trials: systematic review and patient level meta-analysis. BMJ 2008, 337:a1864. 10.1136/bmj.a1864, 2659956, 18977792, Preference Collaborative Review Group.
30. Waber RL, Shiv B, Carmon Z, Ariely D. Commercial features of placebo and therapeutic efficacy. JAMA 2008, 299:1016-1017. 10.1001/jama.299.9.1016, 18319411.
31. Branthwaite A, Cooper P. Analgesic effects of branding in treatment of headaches. Br Med J (Clin Res Ed) 1981, 282:1576-1578. 10.1136/bmj.282.6276.1576, 1505530, 6786566.
32. Schneider R, Grüner M, Heiland A, Keller M, Kujanová Z, Peper M, Riegl M, Schmidt S, Volz P, Walach H. Effects of expectation and caffeine on arousal, well-being, and reaction time. Int J Behav Med 2006, 13:330-339. 10.1207/s15327558ijbm1304_8, 17228991.
33. Cavanna AE, Strigaro G, Monaco F. Brain mechanisms underlying the placebo effect in neurological disorders. Funct Neurol 2007, 22:89-94.